Invention Grant
![Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators](/docs/US/2020-01-07/US10526328B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators
-
Application No.: US16124853Application Date: 2018-09-07
-
Publication No.: US10526328B2Publication Date: 2020-01-07
- Inventor: Lynn Resnick , George T. Topalov , Charles A. Flentge , James S. Hale , David A. Mareska , Justin K. Belardi , Kai Zhang , Scott S. Harried
- Applicant: Knopp Biosciences LLC
- Applicant Address: US PA Pittsburgh
- Assignee: Knopp Biosciences LLC
- Current Assignee: Knopp Biosciences LLC
- Current Assignee Address: US PA Pittsburgh
- Agency: Pepper Hamilton LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
![Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators](/abs-image/US/2020/01/07/US10526328B2/abs.jpg.150x150.jpg)
Abstract:
Compounds represented by formula 1 can be potent and/or partially selective for the Kv7.2/7.3 heteromultimer. They may be useful in treating disorders related to seizures, pain, neurotransmitter release, etc.
Public/Granted literature
- US20190002464A1 IMIDAZO[4,5-B]PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS Public/Granted day:2019-01-03
Information query
